Vivesto AB - Asset Resilience Ratio

Latest as of September 2025: 0.31%

Vivesto AB (VIVE) has an Asset Resilience Ratio of 0.31% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Vivesto AB for a breakdown of total debt and financial obligations.

Liquid Assets

Skr470.00K

≈ $50.58K USD Cash + Short-term Investments

Total Assets

Skr150.01 Million

≈ $16.14 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Vivesto AB's Asset Resilience Ratio has changed over time. See Vivesto AB (VIVE) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Vivesto AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Vivesto AB market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr470.00K	0.31%
Total Liquid Assets	Skr470.00K	0.31%

Asset Resilience Insights

Limited Liquidity: Vivesto AB maintains only 0.31% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Vivesto AB Industry Peers by Asset Resilience Ratio

Compare Vivesto AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd KQ:023910	Drug Manufacturers - Specialty & Generic	11.95%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	Drug Manufacturers - Specialty & Generic	6.02%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Hainan Honz Pharmaceutical Co SHE:300086	Drug Manufacturers - Specialty & Generic	0.27%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%

Annual Asset Resilience Ratio for Vivesto AB (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Vivesto AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	18.23%	Skr31.51 Million ≈ $3.39 Million	Skr172.88 Million ≈ $18.60 Million	-14.74pp
2023-12-31	32.97%	Skr72.75 Million ≈ $7.83 Million	Skr220.67 Million ≈ $23.75 Million	-4.42pp
2022-12-31	37.39%	Skr133.05 Million ≈ $14.32 Million	Skr355.88 Million ≈ $38.30 Million	+22.35pp
2021-12-31	15.04%	Skr89.36 Million ≈ $9.62 Million	Skr594.31 Million ≈ $63.96 Million	-13.60pp
2020-12-31	28.64%	Skr247.28 Million ≈ $26.61 Million	Skr863.54 Million ≈ $92.93 Million	+5.35pp
2019-12-31	23.28%	Skr234.08 Million ≈ $25.19 Million	Skr1.01 Billion ≈ $108.19 Million	+23.28pp
2018-12-31	0.00%	Skr1.00 ≈ $0.11	Skr646.38 Million ≈ $69.56 Million	-3.88pp
2015-12-31	3.88%	Skr20.01 Million ≈ $2.15 Million	Skr515.58 Million ≈ $55.48 Million	-5.87pp
2014-12-31	9.75%	Skr50.15 Million ≈ $5.40 Million	Skr514.57 Million ≈ $55.38 Million	--

pp = percentage points

About Vivesto AB

ST:VIVE Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$5.59 Million

Skr51.93 Million SEK

Market Cap Rank

#28137 Global

#629 in Sweden

Share Price

Skr0.08

Change (1 day)

+3.45%

52-Week Range

Skr0.08 - Skr0.26

All Time High

Skr10.56